Propofol Inhibits Neuronal Differentiation of Mouse Embryonic Stem Cells in Vitro.
Wang Hao,Luo Zhe,Xue Zhang-gang,Cang Jing
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20130856
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:Propofol (2, 6-diisopropylphenol) is a general intravenous anesthetic which plays roles in the central neural system by binding GABAA receptors (GABAARs) and enhancing the chloride channels of the neurons.1 Previous studies mainly focused on the effects of anesthetics on mature neurons, but little attention was paid to their role in early neural differentiation or neural stem cells. Therefore, in the present study, we choose the widely used mouse embryonic cells (ES) cells as the model to investigate the potential effect of propofol on neuronal differentiation. METHODS Cell lines and reagents E14/Tg2a and 46C mouse ES cells (the latter were generated by gene knock-in at the Sox1 locus to insert the eGFP coding sequence2) were kindly provided by Dr. LI Ping at Fudan University. Propofol was purchased from Astrazeneca Co. DMSO and DAPI (4′-6-Diamidino-2-phenylindole) were from Sigma-Aldrich. DMEM minimal medium was purchased from Gibco Company supplemented with 10% FBS, 2 mmol/L L-glutamine, 1/100 non-essential amino acids, 1/100 penicillin/streptomycin, 0.1 mmol/L 2-mercaptoethanol and 1000 U/ml LIF (Chemicon) to make the ES medium. Non-adhesive petri dishes were from Zhejiang Huangyan Dafu Plastic Co., Ltd. Monoclonal anti-mouse β-tubulin-III antibody (TuJ1, IgG) was purchased from R&D Company USA, and the tetracetyl rhodamine isothiocynate (Tritc)-conjugated goat anti-mouse IgG was from the Vector Company, USA. Trizol and DNaseI were from Invitrogen Company and the PrimeScript™ RT kit was from Takara Company. Mouse ES cells culture and neuronal differentiation E14/Tg2a or 46C ES cells were propagated in the presence of LIF (1000 IU/ml) on gelatin-coated dishes. The method for neural induction of ES cells was according to the "4 day−/4 day+" protocol, as described by Kim et al,3 and includes two phases. In the firstphase, ES cells are cultured in non-adhesive petri dishes in ES medium (described in "Methods") without LIF to form the embryoid bodies (EB). In the second phase, neural lineage was induced by exposure of the EB from the 5th culture day to the 8th day to all-trans retinoic acid (ATRA, 10−6 mol/L) in LIF-free ES medium. For terminal differentiation, embryoid bodies at the end of the 8th day were dissociated and plated on poly-L-ornithine and laminin-coated dishes in the same medium. Propofol treatment Propofol was dissolved in DMSO at 100 mmol/L as stock solution and added to the culture medium at final concentrations of 10, 30, and 100 μmol/L. As the vehicle control, an equal volume of DMSO was added to the culture medium and the final concentrations of DMSO in all samples were less than 0.3% (v/v). The duration of propofol or DMSO treatment is shown in the Figure 1.Figure 1.: Propofol inhibits neuronal differentiation of mouse ES cells in vitro. Mouse ES cells were induced for neural differentiation and neural precursor cells derived from day-8 EBs were exposed to 0, 10, 30, and 100 μmol/L propofol. After 4-days of spontaneous differentiation, these cells were stained by neuronal-specific Tuj1 antibody (Red) and the nuclei were stained by DAPI (Blue). A: Immunofluorescence of TuJ1+ cells at day 12. B: Percentage of TuJ1+ cells at day 12. * P <0.05 vs. DMSO-treated control.Immunofluorescence Cells were fixed in 4% paraformal dehyde and permeabilized with 0.2% Trition-X 100/PBS. After blocking with 5% bovine serum/PBS, cells were incubated with 1:1000 primary antibodies to β-tubulin III (TuJ1) for 2 hours, and 1:200 second antibodies for 1 hour. After the cell nuclei were stained by DAPI, the fluorescence was observed and recorded under Olympus B71 microscope. RT-qPCR RT-qPCR was used to detect the mRNA expression of the genes of neural progenitor markers. Total RNA was isolated from cells using Trizol and treated with DNaseI. First-strand cDNA was synthesized from 2 μg of RNA using the PrimeScript™ RT kit according to the protocol provided by the manufacture. The PCR reaction was performed in a 25 μl volume using 2 μl of diluted cDNA (equal to 1/100 RT product) as the template. Relative mRNA expression levels were normalized with RPL19 (internal standard). Quantitative real-time PCR was performed in an ABI PRISM 7300 Sequencing Detector (Applied Biosystems, Foster City, USA) with SYBR green PCR master mix. Specificity of PCR products was verified by melting curve analysis and subsequent agarose gel electrophoresis. Each sample was analyzed in triplicate. Individual primer sequences specific for human genes were designed using the Primer Express 2.0 software and indicated as following: RPL19-F: 5′-GACGGAAGGGCAGGCATATG-3′; RPL19-R: 5′-TGTGGATGTGCTCCATGAGG-3′; Nestin-F: 5′-AGGACCAGGTGCTTGAGAGA-3′; Nestin-R: 5′-TTCGAGAGATTCGAGGGAGA-3′; β-tubulinIII-F: 5′-AAGGCCTTCCTGCACTGGTA-3′; β-tubulinIII-R: 5′-TCTCGGCCTCGGTGAACTC-3′. Statistical analysis All data were presented as mean ± standard deviation (SD). Multiple groups were compared using analysis of variance (ANOVA) followed by Tukey's post hoc procedure. Simple pair wise comparisons were performed using Student's t-test where appropriate. P values less than 0.05 were considered statistically significance. RESULTS In this study, we examined the effect of propofol on neural lineage commitment of mouse ES cells in vitro. FACS analysis showed that 100 μmol/L propofol treatment did not alter the percentages of Sox1-GFP+ cells on day-8 ((78.66±7.45)% vs. (74.39±9.23)%, P=0.5667). RT-qPCR analysis also confirmed that the expression levels of Nestin and Musashi (two neural progenitor markers) are comparable between DMSO and 100 μmol/L propofol-treated EBs on day-8 (data not shown), suggesting that the in vitro neural lineage commitment (from pluripotent ES cells to neural progenitor cells) of mouse ES cells is not affected by propofol, even at high concentration. We then investigated whether propofol influences the neuronal differentiation at a later stage. Neural precursor cells from day-8 EBs were exposed to various concentrations (0, 10, 30, and 100 μmol/L) of propofol for further neuronal differentiation. Immunoflurescence results showed that the percentage of TuJ1+ cells on day-12was reduced in a dose-dependent manner, from (36.00±4.61)% (0 μmol/L) to (32.00±3.28)% (10 μmol/L), (26.00±2.19)% (30 μmol/L), and (21.00±1.27)% (100 μmol/L) (Figure 1A and B). The β-tubulin III transcript level at day-12 was also down-regulated in a similar dose-dependent manner by propofol treatment from day-8 to day-12 (data not shown). DISCUSSION Our results showed that the intravenous anesthetic, propofol, impairs the neuronal differentiation of mouse ES cells.In general, the neuronal differentiation process from ES cells has at least three stages by the conventional differentiation method: (1) EB formation from ES cells, (2) neural induction from early EB cells to neural precursor cells by ATRA, (3) differentiation from neural precursor cells to neurons. Our data show that the inhibitory effect of propofol on neuronal differentiation is specific at the last stage, from neural precursor cells to neurons, but not at early neural induction stages, from ES cells to neural precursor cells. The decrease in neuron number may be caused by decreased proliferation or increased apoptosis. However, we had not found a significant difference in cell apoptosis between the vehicle and propofol-treated cell groups (data not shown). Andang et al showed that activation of GABA (A) receptors leads to hyperpolarization, increased cell volume and accumulation of stem cells in S phase; thereby causing a rapid decrease in cell proliferation.4 Since neural precursor cells also express functional GABA(A) receptor subunits,4 propofol may inhibit proliferation and/ or differentiation of neural precursor cells via targeting GABA(A) receptors. Even sub-anesthetic doses of propofol (1/4 dose required fora surgical plane) induce neuro-apoptosis in the infant mouse brain.5 Propofol also interferes with dendritic development and impacts on the differentiation of immature neuroblasts into GABAergic interneurons.6 More recently, Krzisch et al7 showed that propofol anesthesia impairs the maturation and survival of adult-born hippocampal neurons. However, propofol at clinically relevant concentrations increases in vitro neuronal differentiation of hippocampal neural precursor cells and such an effect is independent of GABA signaling.8 Interestingly, besides neuronal differentiation, it has been reported that propofol can preferably promote Th cells to differentiate into Th1 cells.9 The inconsistent results of the function of propofol may be caused by different cell lines and culture systems. In conclusion, the data presented here clearly demonstrates that propofol inhibits neuronal differentiation of mouse ES cells in vitro. As propofol is a widely used anesthetic in obstetric surgery, there is a critical need to explore whether propofol influences fetal neuronal development in vivo.